Oddifact is a mission-driven company using an AI platform to repurpose biologic therapies (off-label drugs) for approved orphan drug designations in rare diseases. The company has achieved 11 granted FDA Orphan Drug Designations across 16 submissions with 73% workflow automation via AI. Oddifact is not a manufacturer -- it identifies drug repurposing opportunities using AI and pursues regulatory designations.
AI-driven drug repurposing, orphan drug designation submissions, rare disease therapeutics, regulatory dossier development
1 site worldwide
No certifications on file yet.
No reviews available yet.
No documents available.